Clinical Trials for Ovarian Cancer Patients: Why Now?
February 1, 2013 7:44 pmBy: Cory Bentley, PhD & Teresa Gallagher, PhD
Ovarian cancer is a very diverse disease on the molecular level. Different tumors have different key molecular players and potentially different Achilles’ heels. Researchers are making real progress in pinpointing key players … Read more